Farahmand Amirhossein, Sayar Ferena, Omidali Zohreh, Soleimani Mahsa, Jafarzadeh Esfahani Bahareh
Department of Periodontics, Faculty of Dentistry, Islamic Azad University, Tehran, Iran.
Department of Periodontics, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
J Adv Periodontol Implant Dent. 2019 Dec 18;11(2):69-76. doi: 10.15171/japid.2019.012. eCollection 2019.
Pharmacological factors, such as ibuprofen, released topically in the periodontal pocket modulate the host response and enhance the influence of non-surgical periodontal treatment.
In this double-blind, randomized, split-mouth, clinical trial, 38 outpatients with mild to moderate chronic periodontitis were enrolled by applying the simple random sampling method. They had at least one tooth with a periodontal pocket depth of >4 mm in each quadrant and had undergone phase I of periodontal treatment one week after scaling and root planing (SRP). The parameters of clinical periodontal evaluation, including probing pocket depth (PPD), clinical attachment level (CAL), plaque index (PI), and bleeding index (BI), were measured. In addition, two mandibular molar teeth in one quadrant were randomly nominated for subgingival irrigation with 0.5 mL of 2% ibuprofen or placebo mouthwash. The measurements were repeated after at least one week for three months.
Thirty-four individuals (18 women and 16 men), with an age range of 28‒36 years, were evaluated for three months. Moreover, periodontal clinical parameters were assessed within three months. There was a significant improvement in pocket depth (PD) and clinical attachment level (CAL) readings after 12 weeks in both groups (paired t-test). On comparing, the group with scaling and root planing (SRP) + ibuprofen showed more favorable results than the group with SRP + placebo (P<0.05). There were significant improvements in PI and BI in both groups; the differences between the two groups were significant (P<0.05).
The mouthwashes containing ibuprofen might reduce the symptoms of periodontal disease and might be used as an adjunct in the healing process.
布洛芬等药物因子在牙周袋局部释放可调节宿主反应,并增强非手术牙周治疗的效果。
在这项双盲、随机、分口临床试验中,采用简单随机抽样法招募了38例轻至中度慢性牙周炎门诊患者。他们每个象限至少有一颗牙周袋深度>4 mm的牙齿,在龈下刮治和根面平整(SRP)一周后接受了牙周治疗第一阶段。测量了临床牙周评估参数,包括探诊牙周袋深度(PPD)、临床附着水平(CAL)、菌斑指数(PI)和出血指数(BI)。此外,随机指定一个象限中的两颗下颌磨牙用0.5 mL 2%布洛芬或安慰剂漱口水进行龈下冲洗。至少一周后重复测量,持续三个月。
对34名年龄在28至36岁之间的个体(18名女性和16名男性)进行了为期三个月的评估。此外,在三个月内评估了牙周临床参数。两组在12周后牙周袋深度(PD)和临床附着水平(CAL)读数均有显著改善(配对t检验)。相比之下,龈下刮治和根面平整(SRP)+布洛芬组的结果比SRP+安慰剂组更有利(P<0.05)。两组的PI和BI均有显著改善;两组之间的差异具有统计学意义(P<0.05)。
含布洛芬的漱口水可能会减轻牙周疾病的症状,并可作为愈合过程中的辅助用药。